| SIU School of Medicine

News

SIU medical student working with NIH scientists in Washington

Third-year medical student Taylor Badger has embarked upon a unique learning opportunity that adds a year of intensive research experience to her medical school curriculum at Southern Illinois University School of Medicine. This spring she was awarded a position in the National Institutes of Health’s Medical Research Scholars Program (MRSP) class of 2022-23. She moved from her home in Springfield to the NIH campus in Bethesda, MD, to begin a year-long mentored research experience. The prestigious training is awarded to 50 candidates selected from among the top U.S. medical schools. The

News

SIU medical student working with NIH scientists in Washington

Third-year medical student Taylor Badger has embarked upon a unique learning opportunity that adds a year of intensive research experience to her medical school curriculum at Southern Illinois University School of Medicine. This spring she was awarded a position in the National Institutes of Health’s Medical Research Scholars Program (MRSP) class of 2022-23. She moved from her home in Springfield to the NIH campus in Bethesda, MD, to begin a year-long mentored research experience. The prestigious training is awarded to 50 candidates selected from among the top U.S. medical schools. The

News

SIU medical student working with NIH scientists in Washington

Third-year medical student Taylor Badger has embarked upon a unique learning opportunity that adds a year of intensive research experience to her medical school curriculum at Southern Illinois University School of Medicine. This spring she was awarded a position in the National Institutes of Health’s Medical Research Scholars Program (MRSP) class of 2022-23. She moved from her home in Springfield to the NIH campus in Bethesda, MD, to begin a year-long mentored research experience. The prestigious training is awarded to 50 candidates selected from among the top U.S. medical schools. The

News

SIU medical student working with NIH scientists in Washington

Third-year medical student Taylor Badger has embarked upon a unique learning opportunity that adds a year of intensive research experience to her medical school curriculum at Southern Illinois University School of Medicine. This spring she was awarded a position in the National Institutes of Health’s Medical Research Scholars Program (MRSP) class of 2022-23. She moved from her home in Springfield to the NIH campus in Bethesda, MD, to begin a year-long mentored research experience. The prestigious training is awarded to 50 candidates selected from among the top U.S. medical schools. The

General Results

Vascular Surgery faculty

Trial

Pediatrics

A Randomized, Double Blind, Parallel-group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IBP-9414 in Premature Infants 500-1500g Birth Weight in the Prevention of Necrotizing Enterocolitis - The Connection Study

Active recruiting

The purpose of the clinical study is to compare the effectiveness of IBP-9414 treatment against placebo in preventing necrotizing enterocolitis in premature infants.

Treatments: Prevention of necrotizing enterocolitis in premature infants

Trial

Internal Medicine

VICTORION-2 PREVENT: A randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease

Active not recruiting

PURPOSE: The purpose of this clinical trial is to find out if the investigational study treatment, called inclisiran, can help prevent cardiovascular events (such as heart attacks, strokes, and cardiovascular-related deaths) in adults who already have been diagnosed with cardiovascular disease

Trial

Internal Medicine

VICTORION-2 PREVENT: A randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease

Active not recruiting

PURPOSE: The purpose of this clinical trial is to find out if the investigational study treatment, called inclisiran, can help prevent cardiovascular events (such as heart attacks, strokes, and cardiovascular-related deaths) in adults who already have been diagnosed with cardiovascular disease

Trial

Internal Medicine

RADIANCE Continued Access Protocol (CAP): A study of the ReCor Medical Paradise System in Clinical Hypertension

Active not recruiting

The purpose of this clinical trial is to find out if a medical device called the Paradise Renal Denervation System can lower blood pressure in patients who have hypertension

News

Suicide support group to meet this fall

With suicide on the rise within the agriculture community, the Farm Family Resource Initiative is launching an open support group for farmers and farm family members 18 years and older who have lost a loved one to suicide. The group will meet monthly and the meetings will be held virtually. Survivors of suicide loss share a singular bond. While each situation is different, those who have lost a loved one to suicide tend to experience similar feelings and stages of grief, and have similar questions. Support groups provide an opportunity to meet others who understand and are willing to share